Kardigan, Inc. KARD
Set alert
At close · Oct 30
After hours · Oct 30, 5:29 PM ET
- YTD
- -35.77%
- 1 year
- -35.77%
- Open
- 14.25
- Prev close
- 14.31
- Mkt cap
- 1.32B
- Vol
- 452.78K
- Avg vol
- 552.10K
- EPS
- -10.65
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.75
- High
- 14.65
- Forward P/E
- -3.43
- Beta
- 0.00
- Short ratio
- 5.75
- Inst. own
- 78.32%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 10, 2026
- 50-d avg
- 16.46
- 200-d avg
- 19.03
- 1y target
- 39.50
News
3 days ago benzinga.com
This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday
Analysts initiated bullish coverage on Rubrik, Kardigan, MSG Rangers and Ormat Technologies, with price targets of $155, $50, $257 and $123.
3 days ago 247wallst.com
Here Are Thursday’s Top Wall Street Analyst Research Calls: Alphabet, Boston Scientific, eBay, Fervo Energy, Fortinet, Hilton Worldwide Holdings, Lennox International, Palantir Technologies, and More
Pre-Market Stock Futures: Futures are trading lower after a solid day for the stock market, as the interest-rate scenario played out as we (and most across Wall Street) predicted, with the Federal…
-
3 days ago benzinga.com
Cantor Fitzgerald Initiates Coverage On Kardigan with Overweight Rating, Announces Price Target of $50
Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Kardigan (NASDAQ:KARD) with a Overweight rating and announces Price Target of $50.
1 week ago benzinga.com
This Constellation Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Analysts initiated coverage: Buy ratings for CleanSpark, Constellation Energy and Atrium; Outperform for Kardigan; Neutral for Northwest Natural.
-
1 week ago benzinga.com
Baird Initiates Coverage On Kardigan with Outperform Rating, Announces Price Target of $43
Baird analyst Jack Allen initiates coverage on Kardigan (NASDAQ:KARD) with a Outperform rating and announces Price Target of $43.
-
2 weeks ago benzinga.com
UBS Initiates Coverage On Kardigan with Buy Rating, Announces Price Target of $25
UBS analyst Alice Nettleton initiates coverage on Kardigan (NASDAQ:KARD) with a Buy rating and announces Price Target of $25.
1 month ago businesswire.com
Kardigan Announces Appointment of Kristin Reinke to its Board of Directors
SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)---- $KARD #Kardigan--Kardigan announced today the appointment of Kristin Reinke to its Board of Directors, where she will serve as chair…
1 month ago defenseworld.net
Kardigan, Inc. (NASDAQ:KARD) Stock Has Consensus Price Target of $42.25 According to Analysts
Shares of Kardigan, Inc. (NASDAQ: KARD - Get Free Report) have earned an average rating of "Moderate Buy" from the six ratings firms that are currently covering the company, Marketbeat.com reports.…
1 month ago seekingalpha.com
Kardigan: Funded Precision Cardiology Offers More Than Pipeline Diversification
Kardigan targets genetic DCM, moderate CAVS, and post-hospitalization ASH with differentiated, biology-driven clinical programs. KARD holds $660.7M in liquid assets, providing roughly 2–3 years of…
2 months ago businesswire.com
Kardigan to Present at Two September Investor Conferences
SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)---- $KARD #Kardigan--Kardigan will participate in two upcoming investor conferences: 2026 Cantor Global Healthcare Conference and…
-
2 months ago benzinga.com
JP Morgan Maintains Overweight on Kardigan, Lowers Price Target to $46
JP Morgan analyst Anupam Rama maintains Kardigan (NASDAQ:KARD) with a Overweight and lowers the price target from $51 to $46.
2 months ago gurufocus.com
Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates
Kardiganâ¢, Inc. (Nasdaq: KARD) (âKardiganâ or âthe Companyâ), a clinical-stage precision therapeutics company developing medicines that target the roo
-
2 months ago benzinga.com
Kardigan Q2 EPS $(4.61) Misses $(0.71) Estimate
Kardigan (NASDAQ:KARD) reported quarterly losses of $(4.61) per share which missed the analyst consensus estimate of $(0.71) by 549.3 percent. This is a 0.65 percent increase over losses of $(4.64)…
2 months ago businesswire.com
Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates
SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)---- $KARD #CVD--Kardigan™, Inc. (Nasdaq: KARD) today reported financial results from the second quarter ended June 30, 2026, and…
-
3 months ago benzinga.com
TD Cowen Initiates Coverage On Kardigan with Buy Rating, Announces Price Target of $46
TD Cowen analyst Ritu Baral initiates coverage on Kardigan (NASDAQ:KARD) with a Buy rating and announces Price Target of $46.
-
3 months ago benzinga.com
Leerink Partners Initiates Coverage On Kardigan with Outperform Rating, Announces Price Target of $37
Leerink Partners analyst Roanna Ruiz initiates coverage on Kardigan (NASDAQ:KARD) with a Outperform rating and announces Price Target of $37.
3 months ago benzinga.com
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Wall Street analysts changed outlook on top stocks. To see all changes, visit the analyst ratings page. FAST stock has a Buy rating with $55 PT.
-
3 months ago benzinga.com
JP Morgan Initiates Coverage On Kardigan with Overweight Rating, Announces Price Target of $51
JP Morgan analyst Anupam Rama initiates coverage on Kardigan (NASDAQ:KARD) with a Overweight rating and announces Price Target of $51.
-
3 months ago benzinga.com
Jefferies Initiates Coverage On Kardigan with Buy Rating, Announces Price Target of $40
Jefferies analyst Dennis Ding initiates coverage on Kardigan (NASDAQ:KARD) with a Buy rating and announces Price Target of $40.
4 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Abivax (NASDAQ:ABVX) shares increased by 36.0% to $130.74 during Tuesday's pre-market session. The company's market cap stands at $7.6 billion. Cuprina Holdings (Cayman) (NASDAQ:CUPR) shares…
4 months ago businesswire.com
Kardigan Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)---- $KARD #Kardigan--Kardigan announced the closing of its initial public offering.
4 months ago reuters.com
Kardigan rises in Nasdaq debut after upsized $400 million IPO
Kardigan's shares rose 1.6% in their Nasdaq debut on Thursday, after the heart drug developer raised $400 million in an upsized U.S. initial public offering.
4 months ago businesswire.com
Kardigan Announces Pricing of Upsized Initial Public Offering
SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)---- $KARD #Kardigan--Kardigan™, Inc. (Nasdaq: KARD) (“Kardigan”), a clinical-stage precision therapeutics company developing medicines…
4 months ago reuters.com
Heart drug developer Kardigan targets $1.4 billion valuation in US IPO
Kardigan is targeting a valuation of up to $1.4 billion in its initial public offering in the United States, the drug developer said on Thursday.
5 months ago seekingalpha.com
Kardigan Begins Process For IPO On Cardiovascular Treatments Promise
Kardigan, Inc. (KARD) is a clinical-stage biopharma targeting various cardiovascular disease treatments with a pipeline led by Danicamtiv, now in Phase 2b/3 trials. KARD leverages its Prolario AI…